Susquehanna initiates coverage on Theravance, Inc. (Nasdaq: THRX) with a Positive rating. Price target $18.00.

Susquehanna analyst says ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE